Search

Your search keyword '"Zhang Lianwen"' showing total 227 results

Search Constraints

Start Over You searched for: Author "Zhang Lianwen" Remove constraint Author: "Zhang Lianwen"
227 results on '"Zhang Lianwen"'

Search Results

1. Modeling analysis and protection study of vertical and horizontal vibrations in Hami melon logistics packages

2. A Modified Coupled Enzyme Method for O-linked GlcNAc Transferase Activity Assay

6. Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma

7. Identification of TAT as a Biomarker Involved in Cell Cycle and DNA Repair in Breast Cancer.

9. Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity

14. A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses

15. Substrate specificity provides insights into the sugar donor recognition mechanism of O-GlcNAc transferase (OGT).

18. Study on the resonance transfer characteristics of packaging parts for Hami melon logistics stacking and transportation.

19. Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation

21. Abstract CT207: Phase I trial of vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 (VSV-IFNb-TYRP1) in metastatic ocular melanoma

23. EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM

26. Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants

28. Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine

31. An Analysis of Virus Amplification and Antitumor Responses in T-Cell Lymphoma Patients Treated with Voyager-V1 ( VSV-IFNβ-NIS)

32. Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine

34. Glucose Starvation Causes ptauS409 Increase in N2a Cells Through ATF3/PKAcα Signaling Pathway.

35. TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies

36. Poster: TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies

40. Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.

48. Abstract CT090: Rational design of an oncolytic virus permits use of interferon beta as a pharmacodynamic marker for clinical application

Catalog

Books, media, physical & digital resources